NVAX
Novavax Inc
Price:  
8.44 
USD
Volume:  
4,320,694.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax WACC - Weighted Average Cost of Capital

The WACC of Novavax Inc (NVAX) is 7.1%.

The Cost of Equity of Novavax Inc (NVAX) is 7.45%.
The Cost of Debt of Novavax Inc (NVAX) is 5.50%.

Range Selected
Cost of equity 6.20% - 8.70% 7.45%
Tax rate 0.20% - 0.50% 0.35%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.9% - 8.4% 7.1%
WACC

Novavax WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.5 0.68
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.20% 8.70%
Tax rate 0.20% 0.50%
Debt/Equity ratio 0.16 0.16
Cost of debt 4.00% 7.00%
After-tax WACC 5.9% 8.4%
Selected WACC 7.1%